charge—320—320Net income - adjusted$460$535$2,802$2,181ExpandThree Months Ended December 31,Years Ended December 31,Originations2025202420252024Retail finance receivables originations$8,404$10,637$36,314$36,960Lease originations4,2294,94319,56719,089Total originations$12,633$15,580$55,881$56,049ExpandThree Months Ended December 31,Years Ended December 31,Average Earning Assets2025202420252024Average retail finance receivables$75,610$75,318$76,717$73,917Average commercial finance receivables17,33419,60917,20 ...

Core Insights - DaVita faced notable challenges in 2025, including a tough flu season in Q1 and a significant cyber incident in Q2 [2] - Despite these challenges, DaVita managed to maintain its guidance and continue delivering operating results [3] Group 1: Challenges Faced - The primary challenges for DaVita were related to volume, which is a key metric for the company and investors [3] - Revenue per treatment also posed challenges during the year [3] Group 2: Company Performance - DaVita's management effectively handled the cyber incident, showcasing the company's operational resilience [2] - The company is focused on navigating through the challenges while ensuring operational performance remains strong [3]